Delivery Order SPE2DR25D1202-SPE2DR26F73MB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) valued at $1,458.52, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under the contractor's larger pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count) with a ceiling value of $1,871.50. The contract, which is not set-aside, was awarded on November 18, 2025, with an ultimate completion date of November 19, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania under firm fixed-price terms. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) with a ceiling value of $2,305.86. This firm fixed-price delivery order, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a competitively awarded contract with no set-aside designation. The award supports pharmaceutical supply to federal military and healthcare systems, with performance based in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units) with a firm fixed price ceiling value of $1,167.72. The award was made on a non-competitive, non-set-aside basis and is scheduled for completion by December 17, 2025. This delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government, leveraging...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for OxyContin ER 10 mg tablets (100-count units) with a ceiling value of $1,408.24. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by December 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100-count units) with a ceiling value of $1,766.17. This firm fixed-price, non-set-aside delivery order was awarded on September 5, 2025, with an ultimate completion date of September 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count bottles) valued at $2,559.11, with an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The contractor will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count) with a contract ceiling value of $2,640.14. The order, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a firm fixed-price delivery against AmerisourceBergen's larger pharmaceutical supply contract. The contract carries no set-aside designation, indicating it was awarded through open competition. Performance will be executed...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $2,370.38 delivery order contract on September 18, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). The contract is structured as a firm fixed-price delivery order with a completion date of September 19, 2025, and represents a non-set-aside competitive award. The awardee will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100-count) valued at $1,908.93, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F73MBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) valued at $1,310.59 with a firm fixed price structure. This non-set-aside, competitively awarded delivery order was issued on December 29, 2025, with an ultimate completion date of December 30, 2025. The contractor will perform from its corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen Drug Corp's broader relationship with the federal government as a primary pharmaceutical distributor. This delivery order falls under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates its capacity to meet Defense Health Agency and other government healthcare system requirements through flexible and competitively awarded contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/28/25 |